Nestle India Q4 Results: Nestle said its board approved execution of a definitive agreement to form a joint venture with Dr Reddy s Laboratories. The partners intend to bring together a global range of nutritional health solutions as well as vitamins, minerals and health supplements of Nestle Health Science. The joint venture is expected to become operational in the second quarter of the financial year 2024-25, subject to customary closing conditions, the FMCG firm said.
Nestle India Q4 results: The FMCG giant reported a net profit of Rs 934 crore for the three months ended March 31, 2024 (Q4 FY24), a jump of 26.73 per cent from Rs 737 crore a year earlier.
Nestle India Q4 Results: Company recommends a final dividend of Rs 8.50 per equity shares of Re 1 each for the 15 months financial year ended March 31, 2024; Net Profit Jumps 26.7% YoY To Rs 934 Crore, Rs 8.50 Dividend Declared
Nestle Q4 Profit: Nestle India s total revenue from operations also increased to Rs 4,600.42 crore in Q4 CY24 as compared to Rs 4256.79 crore in a similar period last fiscal. Its total expenses rose to Rs 3,636.94 crore in Q4 CY24 from Rs 3,427.27 crore in Q4 CY23, as per the regulatory filing.
Nestle India s net profit for the December quarter is seen rising 18% YoY to Rs 745 crore, according to the average of estimates given by eight brokerage firms. Revenue is seen rising 10.3% to Rs 4,697 crore and the operating profit by 15.3% to Rs 1,126 crore.